At a glance
- Originator LEO Pharma AB
- Class Antiarrhythmics; Guanidines
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 13 May 2003 Discontinued - Preclinical for Arrhythmias in Sweden (unspecified route)
- 01 Apr 1997 No-Development-Reported for Arrhythmias in Sweden (Unknown route)
- 24 Oct 1994 Preclinical development for Arrhythmias in Sweden (Unknown route)